News Headlines

Display #
Title
Alzheimer's and Parkinson's spurred by same enzyme
Merck awards €1.25 million to research projects through its 2017 Grant for Fertility Innovation (GFI)
New brain cancer drug targets revealed
Interleukin Genetics Slashes 63 Percent of Workforce, Shuts Down Program and Mulls Sale
Bay Area’s Coherus Dealt Another Blow as Daiichi Sankyo Discontinues Work on RA Drug
Opdivo Prevails in Phase III Melanoma Trial
Array BioPharma Submits NDAs To FDA
Poll: Americans Overwhelmingly Want More Health Plan Choices than Obamacare Alone
Threat to HIV business spooks GlaxoSmithKline shares
Jardiance® (empagliflozin) analysis reinforces established safety profile
The most efficient option for treating unexplained infertility
Cancer researchers overestimate reproducibility of preclinical studies
FDA Grants Priority Review to HIV Monoclonal Antibody and Long-Acting Investigational Antiretroviral Ibalizumab
Oklahoma sues opioid drugmakers; New Hampshire presses epidemic probe
GSK signs AI drug discovery deal
‘Brain training’ app improves memory in people with cognitive decline
Roche acquires mySugr to form a leading open platform for digital diabetes management
Olumiant approved in Japan for RA treatment
Monster Digital and Innovate Biopharmaceuticals Sign Merger Agreementm
Celebrate Your Independence From Your Health Condition With The Launch Of Cancer-Go
'More than Systemic Sclerosis: The Inside Story' - patients reveal the unseen impact of lung fibrosis
First Scientifically Validated Symptom Checker with Artificial Intelligence Launches in the United States
Acorda Submits New Drug Application to U.S. Food and Drug Administration for Inbrija (CVT-301, Levodopa Inhalation Powder)
FDA Approves Vectibix For Use In Wild-Type RAS Metastatic Colorectal Cancer
Older Americans don't get - or seek - enough help from doctors & pharmacists on drug costs
Shire to Consolidate 3,000+ Jobs Over 4 Years to 2 Massachusetts Sites
Pfizer’s Besponsa Approved in EU
Roche buys diabetes app firm
BioMarin Submits Pegvaliase Biologics License Application to the U.S. FDA for Treatment of Phenylketonuria
Pfizer breaks ground on new R&D facility in Chesterfield, Missouri